Author Question: Mark Smith, a 35-year-old African-American male, is observed to have skin that is ashen gray in ... (Read 77 times)

NguyenJ

  • Hero Member
  • *****
  • Posts: 516
Mark Smith, a 35-year-old African-American male, is observed to have skin that is ashen gray in color; he is oliguric and restless. You might suspect that Mr. Smith may be experiencing:
 
  A.
  Iron deficiency anemia.
  B.
  Pernicious anemia.
  C.
  Hyperglycemia.
  D.
  Renal failure.

Question 2

Birthmarks, defined as irregularities in pigmentation, generally occur in:
 
  A.
  5 of American Indians.
  B.
  10 of White Americans.
  C.
  16 of Mexican Americans.
  D.
  20 of Black Americans.



Brenm

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

ANS: D

Answer to Question 2

ANS: D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The ratio of hydrogen atoms to oxygen in water (H2O) is 2:1.

Did you know?

A strange skin disease referred to as Morgellons has occurred in the southern United States and in California. Symptoms include slowly healing sores, joint pain, persistent fatigue, and a sensation of things crawling through the skin. Another symptom is strange-looking, threadlike extrusions coming out of the skin.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

For a complete list of videos, visit our video library